Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act

Atrial fibrillation (AF) is a major global health burden because of its rising prevalence and associated complications such as stroke and mortality.1 In the 2010 Global Burden of Disease study, approximately 33 million people were estimated to have AF, but this number is projected to increase exponentially due to the ageing population1
Source: Heart Rhythm - Category: Cardiology Authors: Tags: Editorial Commentary Source Type: research